Ribophorin-1 Governs Spike Abundance of Highly Pathogenic Coronaviruses by ER-associated degradation
Huang, Y.-J.; Lv, L.; Ran, W.; Zhao, H.; Deng, Y.-Q.; Ye, Q.; Li, L.; Wu, X.-Y.; Chen, Q.; Hu, Y.; Sun, B.; Zhao, J.-J.; Zhao, J.; Qin, C.
Show abstract
The spike protein of highly pathogenic coronaviruses is indispensable for viral entry, pathogenesis, and immune evasion. However, specific host factors governing spike protein degradation and abundance on progeny virions remain largely uncharacterized. Here, we identify Ribophorin-1 (RPN1), a non-catalytic subunit of the oligosaccharyltransferase (OST) complex, as an ER-localized host restriction factor that selectively depletes spike to inhibit coronavirus infection. Conditional knockout of Rpn1 in mouse lung markedly exacerbates SARS-CoV-2 pathogenesis, increasing viral load, immune cell infiltration, and syncytium formation. In cells, RPN1 knockdown enhances susceptibility to diverse variants, whereas its overexpression attenuates infection. Nano-flow cytometry, cryo-EM and LSCM show that RPN1 reduces spike abundance on progeny virions, resulting in reduction in subsequent syncytium formation across SARS-CoV, SARS-CoV-2, and MERS-CoV. Mechanistically, RPN1 promotes VCP/p97-dependent retrotranslocation and AMFR-mediated ubiquitination of spike protein. Heterologous expression of RPN1s functional domain (residues 180-307) confers significant protection against SARS-CoV-2 both in vitro and in vivo. Collectively, our findings define an RPN1-initiated ERAD pathway that selectively targets coronavirus spike for proteasomal destruction, and provide proof-of-concept evidence that targeting this RPN1-dependent pathway represents a promising broad-spectrum antiviral strategy.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Spike mutation D614G alters SARS-CoV-2 fitness and neutralization susceptibility 97%
- Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity in uninfected and previously infected individuals 96%
- Limited Cross-Variant Immunity after Infection with the SARS-CoV-2 Omicron Variant Without Vaccination 96%
Similar papers in this journal
- Antigenic mapping and functional characterization of human New World hantavirus neutralizing antibodies 96%
- Identification of a conserved neutralizing epitope present on spike proteins from all highly pathogenic coronaviruses 96%
- c-Myc plays a key role in IFN-γ induced persistence of Chlamydia trachomatis 96%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.